169 related articles for article (PubMed ID: 35428811)
1. Comparison of treatment strategies and survival of early-onset gastric cancer: a population-based study.
Zhang C; Tang R; Zhu H; Ge X; Wang Y; Wang X; Miao L
Sci Rep; 2022 Apr; 12(1):6288. PubMed ID: 35428811
[TBL] [Abstract][Full Text] [Related]
2. Comparison of survival between diffuse type and intestinal type early-onset gastric cancer patients: A large population-based study.
Wang Q; Wang T
Medicine (Baltimore); 2023 Nov; 102(47):e36261. PubMed ID: 38013337
[TBL] [Abstract][Full Text] [Related]
3. Variation in Treatment Patterns of Patients with Early-Onset Gastric Cancer.
LaPelusa M; Shen C; Gillaspie EA; Cann C; Lambright E; Chakravarthy AB; Gibson MK; Eng C
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35892891
[TBL] [Abstract][Full Text] [Related]
4. Individualized prediction of survival benefits from perioperative chemoradiotherapy for patients with resectable gastric cancer.
Che K; Liu F; Wu N; Liu Q; Yuan L; Wei J
Cancer Med; 2020 Oct; 9(19):7137-7150. PubMed ID: 32810384
[TBL] [Abstract][Full Text] [Related]
5. Distinguish the Role of Radiotherapy From Chemoradiotherapy for Gastric Cancer With Behavior of Metastasis-Indolent in Lymph Node.
Zhi Y; Lin Z; Ma J; Mou W; Chen X
Technol Cancer Res Treat; 2020; 19():1533033820959400. PubMed ID: 33148125
[TBL] [Abstract][Full Text] [Related]
6. Chemoradiation Improves Survival Compared With Chemotherapy Alone in Unresected Nonmetastatic Gastric Cancer.
Li R; Hou WH; Chao J; Woo Y; Glaser S; Amini A; Nelson RA; Chen YJ
J Natl Compr Canc Netw; 2018 Aug; 16(8):950-958. PubMed ID: 30099371
[No Abstract] [Full Text] [Related]
7. Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis.
Cheong JH; Yang HK; Kim H; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Kim HY; Lee J; Choi SH; Hong S; Kim JW; Choi YY; Hyung WJ; Jang E; Kim H; Huh YM; Noh SH
Lancet Oncol; 2018 May; 19(5):629-638. PubMed ID: 29567071
[TBL] [Abstract][Full Text] [Related]
8. Perioperative chemotherapy versus postoperative chemoradiotherapy in patients with resectable gastric/gastroesophageal junction adenocarcinomas: A survival analysis of 5058 patients.
Fitzgerald TL; Efird JT; Bellamy N; Russo SM; Jindal C; Mosquera C; Holliday EG; Biswas T
Cancer; 2017 Aug; 123(15):2909-2917. PubMed ID: 28386965
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial.
Cats A; Jansen EPM; van Grieken NCT; Sikorska K; Lind P; Nordsmark M; Meershoek-Klein Kranenbarg E; Boot H; Trip AK; Swellengrebel HAM; van Laarhoven HWM; Putter H; van Sandick JW; van Berge Henegouwen MI; Hartgrink HH; van Tinteren H; van de Velde CJH; Verheij M;
Lancet Oncol; 2018 May; 19(5):616-628. PubMed ID: 29650363
[TBL] [Abstract][Full Text] [Related]
10. Risk-Dependent Conditional Survival and Failure Hazard After Radiotherapy for Early-Stage Extranodal Natural Killer/T-Cell Lymphoma.
Liu X; Wu T; Zhu SY; Shi M; Su H; Wang Y; He X; Xu LM; Yuan ZY; Zhang LL; Wu G; Qu BL; Qian LT; Hou XR; Zhang FQ; Zhang YJ; Zhu Y; Cao JZ; Lan SM; Wu JX; Qi SN; Yang Y; Li YX
JAMA Netw Open; 2019 Mar; 2(3):e190194. PubMed ID: 30821826
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathological characteristics of gastric cancer in adolescents aged 10-24 years: 17-year experience of 17 years in a single institute].
Zhang W; Liang WQ; Cai AZ; Wang PP; Xi HQ; Liu GX; Wei B
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):963-968. PubMed ID: 33053991
[No Abstract] [Full Text] [Related]
12. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of clinicopathological features and prognosis analysis between carcinoma in the remnant stomach and gastric cancer].
Li F; Wang Y; Li C; Ma Y; Zhang Y; Li Z; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 May; 21(5):529-534. PubMed ID: 29774934
[TBL] [Abstract][Full Text] [Related]
14. Role of sequential chemoradiotherapy in stage II and low-risk stage III-IV nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy: A propensity score-matched analysis.
Xu C; Sun R; Tang LL; Chen L; Li WF; Mao YP; Zhou GQ; Guo R; Lin AH; Sun Y; Ma J; Hu WH
Oral Oncol; 2018 Mar; 78():37-45. PubMed ID: 29496056
[TBL] [Abstract][Full Text] [Related]
15. Combination of lymphovascular invasion and the AJCC TNM staging system improves prediction of prognosis in N0 stage gastric cancer: results from a high-volume institution.
Lu J; Dai Y; Xie JW; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Zheng CH; Li P; Huang CM
BMC Cancer; 2019 Mar; 19(1):216. PubMed ID: 30857518
[TBL] [Abstract][Full Text] [Related]
16. Accuracy of a Staging System for Prognosis of 5-Year Survival of Patients With Nasopharyngeal Carcinoma Who Underwent Chemoradiotherapy.
Huang CI; Chen LF; Chang SL; Wu HC; Ting WC; Yang CC
JAMA Otolaryngol Head Neck Surg; 2017 Nov; 143(11):1086-1091. PubMed ID: 28975193
[TBL] [Abstract][Full Text] [Related]
17. [Influence of different biological behaviors on prognosis of patients with advanced gastric cancer at the same TNM stage].
Gong YB; Zhu Z; Wang X; Xu HM
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):953-962. PubMed ID: 33053990
[No Abstract] [Full Text] [Related]
18. [Pathological staging criteria for carcinoma in the remnant stomach: an exploratory study].
Gao Z; Zhao X; Jiang K; Wang B; Li Y; Ye Y; Wang S
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 May; 21(5):514-521. PubMed ID: 29774932
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of addition of conventional treatment to concurrent chemoradiotherapy in patients with FIGO stage III-IV cervical cancer: a retrospective analysis of a Japanese cohort.
Kurosu H; Todo Y; Yamada R; Minowa K; Tsuruta T; Minobe S; Nishiyama N; Kato H
Jpn J Clin Oncol; 2022 Mar; 52(3):244-250. PubMed ID: 34891157
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of clinicopathological characteristics and prognosis on 42 patients with primary gastric adenosquamous cell carcinoma].
Li B; Sun L; Wang X; Deng J; Ding X; Wang X; Ke B; Zhang L; Zhang R; Liang H
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):207-212. PubMed ID: 28226357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
